NYSE · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Catheter Precision, Inc. VTAK
9 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$819,000
▲ 95.0% vs FY2024
EPS · FY25
—
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-182.7%
Net margin · FY25
-2098.0%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 819,000.00
Revenue, FY2025 · full 9-year series below
Revenue
Net income
The company lost 2098 cents on every revenue dollar this year.
Per share
—
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-182.7%
Return on equity, FY2025
ROE
Operating margin-2581.6%
Net margin-2098.0%
Return on assets-78.8%
Each USD of equity lost 183 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+25.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+288.2%
+25.9%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.00B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 15.9M
total assets, end of FY2025
Total assetsUSD 15.9M
EquityUSD 7.1M
CashUSD 88,000.00
Gross debtUSD 3.1M
Net debtUSD 3.0M
Current ratio0.10×
Net debt stands at 42% of equity.
History
9 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
−0.1
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
−0.1
−0.0
−0.0
Income tax $B
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
−0.1
−0.0
−0.0
EPS, diluted $
·
·
·
−25.98
−248.22
−21.22
−108.28
−3.34
−2.35
Dividend / sh $
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
ROE %
−182.7
−101.0
−463.5
−234.3
−144.0
−132.8
−114.1
−104.3
·
Shares out B
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
36 of 36
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed